NDC 49884-148
Dexlansoprazole
Dexlansoprazole
Dexlansoprazole is a Oral Capsule, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Par Pharmaceutical, Inc.. The primary component is Dexlansoprazole.
| Product ID | 49884-148_4d67a5db-727c-40dc-b983-504308119926 |
| NDC | 49884-148 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Dexlansoprazole |
| Generic Name | Dexlansoprazole |
| Dosage Form | Capsule, Delayed Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-11-22 |
| Marketing Category | ANDA / |
| Application Number | ANDA202294 |
| Labeler Name | Par Pharmaceutical, Inc. |
| Substance Name | DEXLANSOPRAZOLE |
| Active Ingredient Strength | 60 mg/1 |
| Pharm Classes | Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |